Immune Status in Solid Organ Transplantation
Completed
Conditions studied: Organ Transplants
In brief
Immunosuppressive therapy protocols in solid organ transplantation are rudimentary, differ by transplant center and no practical strategies are available to guide an individuals' response to immune suppression. In this study we will conduct research to assess immunologic status in solid organ transplant recipients, predicting immune reconstitution and outcomes after transplant to better guide the use of immunosuppressive medications.
Key facts
- Study ID
- NCT01070901
- Run by
- Dartmouth-Hitchcock Medical Center
- People needed
- 20
- Starts
- 2010-05-01
- Expected to finish
- 2012-03-01
- Last updated by the study team
- 2013-02-05
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Impending kidney transplant
- Age >18
- Able to provide informed consent and comply with the study procedures
You may not qualify if…
- Age<18
- Concomitant illness, which by decision of investigator, may compromise the ability to perform this trial
Where it is running
- Dartmouth-Hitchcock Medical Center — Lebanon, New Hampshire, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.